ARID1B and cancer: Another study demonstrated that the chromatin-remodeling factor ARID1B, forming the BAF complex together with ARID1A, represses the Wnt/ß-Catenin signaling pathway indicating this might contribute to cancer through deregulation of developmental and oncogenic pathways [52].